Publications by authors named "Sarah E May"

Claim this Profile
L
Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.
Rosa Lapalombella, Leslie Andritsos, Qing Liu, Sarah E May, Rebekah Browning

Blood· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia.
Leslie A Andritsos, Amy J Johnson, Gerard Lozanski, William Blum, Cheryl Kefauver, Sarah E May

J Clin Oncol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis